Business Wire

GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma

LONDON & BRISBANE, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of ...
Seeking Alpha

Expanded use of Glaxo's Relvar Ellipta OK'd in Europe

The European Commission approves new labeling for GlaxoSmithKline's (NYSE:GSK) Relvar Ellipta (fluticasone furoate/vilanterol) to include patients adequately controlled on both an inhaled ...
Business Wire

Innoviva Reports Fourth Quarter 2020 Financial Results

Pavel Raifeld, Chief Executive Officer of Innoviva, Inc., stated: “ RELVAR ® /BREO ® ELLIPTA ® global net sales increased by 5%, ANORO ® ELLIPTA ® global net sales increased by 10%, and TRELEGY ® ...
FiercePharma

RELVAR™ ELLIPTA™ gains approval in Japan for the treatment of asthma

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment ...
Medscape

EC Approves Fluticasone Furoate/Vilanterol for Asthma, COPD

The European Commission has granted marketing approval for fluticasone furoate/vilanterol (FF/VI) (Relvar Ellipta, GlaxoSmithKline and Theravance) for the treatment of asthma and chronic obstructive ...
FiercePharma

GSK and Theravance announce positive data from two studies evaluating the efficacy and safety of Incruse™ Ellipta® when added to Relvar®/Breo® Ellipta® in patients with COPD

GSK and Theravance announce positive data from two studies evaluating the efficacy and safety of Incruse™ Ellipta® when added to Relvar®/Breo® Ellipta® in patients with COPD GlaxoSmithKline plc ...
Insider Monkey

Relvar Ellipta: GlaxoSmithKline and Theravance’s Drug for Respiratory Diseases

Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar Ellipta has been in the ...
Business Insider

Innoviva, GSK: EU Approves Label Update To Relvar Ellipta In Asthma Patients

(RTTNews) - Innoviva, Inc. (INVA) and GlaxoSmithKline plc (GSK, GSK.L) announced Thursday that the European Commission has approved a label update to Relvar Ellipta in patients with asthma. The label ...
London South East

GSK's Relvar Ellipta - positive CHMP opinion

GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma Jonathan Sweeting, SVP and Global Head of Respiratory Franchise GSK, said: "There are many asthma ...
Yahoo Finance

Patient Recruitment Completes in Landmark RELVAR(R)/BREO(R) ELLIPTA(R) Study to Understand Mortality and MorbidITy (SUMMIT) in COPD

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Marketwired - Mar 13, 2014) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that recruitment of ...
London South East

Positive results for Relvar Ellipta Lung Study

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with ...
PharmaTimes

GSK’s Relvar Ellipta hits the mark in COPD trial

A "ground-breaking" UK study has shown that GlaxoSmithKline's Relvar Ellipta is better than the standard of care in reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) ...